Fingerprint
Dive into the research topics of 'Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
Beatriz Gros*, Nikolas Plevris, Nathan Constantine-Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Lauranne A A P Derikx
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review